SEC Form 4 · accession 0001179110-17-003082
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David B Zenoff
Director
Period of report
Feb 21, 2017
Accepted (ET)
Feb 23, 2017 · 7:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 21, 2017 | M | 25,000 | $3.59 | A | 48,999 | I | By Family Trust |
| Common Stock | Feb 21, 2017 | M | 15,000 | $3.27 | A | 63,999 | I | By Family Trust |
| Common Stock | Feb 21, 2017 | M | 15,000 | $1.49 | A | 78,999 | I | By Family Trust |
| Common Stock | Feb 21, 2017 | M | 15,000 | $3.45 | A | 93,999 | I | By Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common StockF1 | $3.59 | Feb 21, 2017 | M | 25,000 | A | — | Mar 21, 2017 | Common Stock | 25,000 | 0 | D |
| Common StockF2 | $3.27 | Feb 21, 2017 | M | 15,000 | A | — | Dec 6, 2017 | Common Stock | 15,000 | 0 | D |
| Common StockF3 | $1.49 | Feb 21, 2017 | M | 15,000 | A | — | Dec 9, 2018 | Common Stock | 15,000 | 0 | D |
| Common StockF4 | $3.45 | Feb 21, 2017 | M | 15,000 | A | — | Dec 7, 2019 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F125,000 Stock Options were granted on March 21, 2007 and were exercisable in 48 equal monthly installments. The Stock Options exercised on February 21, 2017 were Non-Qualified Stock Options (NSOs).
- F215,000 Stock Options were granted on December 6, 2007 and were exercisable in 12 equal monthly installments. The Stock Options exercised on February 21, 2017 were Non-Qualified Stock Options (NSOs).
- F315,000 Stock Options were granted on December 9, 2008 and were exercisable in 12 equal monthly installments. The Stock Options exercised on February 21, 2017 were Non-Qualified Stock Options (NSOs).
- F415,000 Stock Options were granted on December 7, 2009 and were exercisable in 12 equal monthly installments. The Stock Options exercised on February 21, 2017 were Non-Qualified Stock Options (NSOs).